Skip to content
Lower risk Drug recall · FDA · Published February 26, 2021

Dr. Red: Progesterone Capsules 200mg Risk of Inconsistent Dissolution

Dr. Reddy's recalls 200mg progesterone capsules (100-count) made in France due to dissolution testing failures. Rx-only product with batch #1399851P1.

🇺🇸 FDA recall #D-0292-2021DrugDr. Reddy's ›
Take action

Contact the company

Recalling firmDr. Reddy's Laboratories, Inc.107 College Rd E · Princeton, NJ 08540-6623
✎ GovInfoNow plain-language explainer

Dr. Reddy's is recalling 200mg progesterone capsules (100-count bottles) made in France because lab tests showed inconsistent dissolution. This could affect medication reliability for patients using these prescription capsules. Read more at govinfonow.com/recall/36498-dr-red-progesterone-capsules-200mg-risk-of-inconsistent-dissolution.

Source Summary by GovInfoNow · govinfonow.com/recall/36498-dr-red-progesterone-capsules-200mg-risk-of-inconsistent-dissolution · Updated October 4, 2026 · FDA enforcement record: FDA #D-0292-2021

Cite this page

“Dr. Red: Progesterone Capsules 200mg Risk of Inconsistent Dissolution.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36498-dr-red-progesterone-capsules-200mg-risk-of-inconsistent-dissolution. Based on FDA recall #D-0292-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0292-2021%22&limit=1).

The FDA announced on Feb. 26, 2021, that Dr. Reddy's Laboratories, Inc. voluntarily recalled Progesterone Capsules due to failed dissolution specifications. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Dr. Reddy's
  • Product: Progesterone Capsules, 200 mg, 100-count bottles
  • NDC: 43598-350-01
  • Batch #: 1399851P1
  • Expiration Date: 02/2021
  • Quantity: 16,449 bottles

The hazard

The recall stems from out-of-specification results observed for dissolution during stability testing. The FDA said the product did not meet required dissolution specifications.

Context

GovInfoNow's records show Dr. Reddy's Laboratories, Inc. has 85 other recalls on record since April 9, 2012. Other recent recalls of similar products include Dr. Reddy's Varenicline Tablets Recall (Nov. 11, 2025), Dr. Reddy's Succinylcholine Chloride Injection Recall (Sept. 26, 2025), and Dr. Reddy's Omeprazole Capsules Recall (June 30, 2025). Other recent recalls of similar products include Supernus Trokendi XR 25mg Capsules (July 6, 2026), Sun Pharmaceutical Lisdexamfetamine Capsules Recall (Oct. 28, 2025), and Supernus Trokendi XR 50mg Capsules (Aug. 31, 2026).

How to tell if you have this one

Check for the 100-count bottles labeled 'Progesterone Capsules, 200 mg, Rx Only' made in France. Look for batch number 1399851P1 with expiration 02/2021.

  • Brand
    Dr. Reddy's
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the batch number and expiration date on the capsule bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Feb 26, 202112. FDA classified it Class II: Mar 3, 202123. Published in FDA’s Enforcement Report: Mar 10, 202134. FDA terminated the recall: Feb 17, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is due to lab testing issues, not immediate safety risks. The product may not dissolve properly, but no injuries have been reported.

Similar recalls

Other Dr. Reddy's recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0292-2021 (February 26, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0292-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA